GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SPA (NYSE:STVN) » Definitions » EV-to-FCF

Stevanato Group SPA (Stevanato Group SPA) EV-to-FCF : -22.20 (As of May. 03, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stevanato Group SPA EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Stevanato Group SPA's Enterprise Value is $8,048 Mil. Stevanato Group SPA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-363 Mil. Therefore, Stevanato Group SPA's EV-to-FCF for today is -22.20.

The historical rank and industry rank for Stevanato Group SPA's EV-to-FCF or its related term are showing as below:

STVN' s EV-to-FCF Range Over the Past 10 Years
Min: -458.38   Med: -34.7   Max: 243.05
Current: -22.2

During the past 6 years, the highest EV-to-FCF of Stevanato Group SPA was 243.05. The lowest was -458.38. And the median was -34.70.

STVN's EV-to-FCF is ranked worse than
100% of 367 companies
in the Medical Devices & Instruments industry
Industry Median: 27.39 vs STVN: -22.20

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-03), Stevanato Group SPA's stock price is $26.81. Stevanato Group SPA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.593. Therefore, Stevanato Group SPA's PE Ratio for today is 45.21.


Stevanato Group SPA EV-to-FCF Historical Data

The historical data trend for Stevanato Group SPA's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stevanato Group SPA EV-to-FCF Chart

Stevanato Group SPA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - 251.28 -31.84 -20.70

Stevanato Group SPA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.84 -36.30 -38.09 -28.28 -20.70

Competitive Comparison of Stevanato Group SPA's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Stevanato Group SPA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stevanato Group SPA's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SPA's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Stevanato Group SPA's EV-to-FCF falls into.



Stevanato Group SPA EV-to-FCF Calculation

Stevanato Group SPA's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=8048.253/-362.587
=-22.20

Stevanato Group SPA's current Enterprise Value is $8,048 Mil.
Stevanato Group SPA's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-363 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stevanato Group SPA  (NYSE:STVN) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Stevanato Group SPA's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=26.81/0.593
=45.21

Stevanato Group SPA's share price for today is $26.81.
Stevanato Group SPA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.593.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Stevanato Group SPA EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Stevanato Group SPA's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Stevanato Group SPA (Stevanato Group SPA) Business Description

Traded in Other Exchanges
Address
Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% from South America. It has two segments Biopharmaceutical and Diagnostic Solutions and Engineering.